Australia faces a nation-wide shortage of methylphenidate (sold as Concerta and Ritalin). ADHD medication shortages have ...

Researchers analysed data on five licensed ADHD medications, including stimulants like methylphenidate, dexamfetamine, and ...

Labels of all extended-release stimulants indicated for ADHD -- including certain formulations of amphetamine and ...

The U.S. Food and Drug Administration is revising the labeling of all extended-release attention-deficit/hyperactivity ...

The U.S. Food and Drug Administration is revising the labeling of all extended-release attention-deficit/hyperactivity ...

Medications for attention-deficit/hyperactivity disorder (ADHD) have some side effects that are common, while others are more ...

Kids younger than 6 years on extended-release stimulants for ADHD may experience higher rates of side effects due to higher plasma exposures.

The ‘severe, persistent, and disruptive’ shortages often impact patients with ADHD, menopause and diabetes, a new report says ...

Instead, participants said, classifying methylphenidate a schedule 6 drug “ negatively impacts on treatment adherence ”. Our medicines regulator, the South African Health Products Regulatory Authority ...

The findings also highlight how shortages severely impact patients with conditions like ADHD, menopause and diabetes.

The agency said it assessed data from clinical trials of extended-release formulations of amphetamine and methylphenidate for ADHD treatment, finding that, compared to older children, patients ...

A new generation of long-acting methylphenidate formulations are now available for the treatment of ADHD. This review analyzes 34 comparative studies to help inform clinical decision-making.